Market Research Logo

Immunoprecipitation Market by Product (Kit, Reagent (Antibodies, Magnetic Buffer)), Type (Individual IP, Coimmunoprecipitation, CHIP), End User (Academics, Research Institutes, Pharmaceutical and Biotechnology Companies) - Global Forecast to 2024

Immunoprecipitation Market by Product (Kit, Reagent (Antibodies, Magnetic Buffer)), Type (Individual IP, Coimmunoprecipitation, CHIP), End User (Academics, Research Institutes, Pharmaceutical and Biotechnology Companies) - Global Forecast to 2024

“Increasing research activity in the life sciences industry is expected to drive the overall growth of the immunoprecipitation market.”
The immunoprecipitation market is projected to reach USD 750 million by 2024 from USD 560 million in 2018, at CAGR of 5.0% during forecast period. The growth of this market is majorly driven by the increasing number of research activities in the life sciences industry and the growing need to identify antigens associated with autoimmune diseases (through antigen-antibody interaction to understand disease mechanisms and develop relevant drugs targeting these diseases). However, the presence of alternative technologies for protein purification is expected to restrain the growth of this market in the coming years.

“The kits segment is expected to grow at the highest CAGR during the forecast period.”
The immunoprecipitation market, by product, has been categorized into three major segments— kits, reagents, and accessories. The kits segment is estimated to grow at the highest CAGR from 2018 to 2024. The need for repeat purchase of kits, coupled with the increasing number of IP assays to isolate and purify antigens, forms a major driver for the growth of this segment.

“The pharmaceutical & biotechnology companies segment is expected to grow at the highest CAGR during the forecast period.”
The immunoprecipitation market, by end user, has been categorized into three major segments—academic & research institutes, pharmaceutical & biotechnology companies, and contract research organizations (CROs). The pharmaceutical & biotechnology companies segment is estimated to grow at the highest CAGR from 2018 to 2024. The increasing demand for protein-based drugs to drive the demand for immunoprecipitation in this end-user segment will support market growth.

“Asia Pacific projected to grow at the highest CAGR during the forecast period.”
In the immunoprecipitation market, Asia Pacific is projected to record the highest growth during the forecast period. China, Japan, and India are the major markets for immunoprecipitation in the Asia Pacific. Increasing investments by governments and industries, growing biotechnology research in these regions, and rising awareness about personalized therapeutics are expected to drive the growth of these markets during the forecast period.

In-depth interviews were conducted with Chief Executive Officers (CEOs), marketing directors, other innovation and technology directors, and executives from various key organizations operating in the immunoprecipitation market.

By Company Type: Tier 1-48%, Tier 2-34%, and Tier 3-18%
By Designation: C-level Executives-42%, Directors-40%, and Others-18%
By Region: North America-38%, Europe-25%, APAC-30%, and RoW-7%

The immunoprecipitation market comprises major providers such as Thermo Fisher Scientific (US), Abcam (UK), Merck KGaA (Germany). The study includes an in-depth competitive analysis of these key players in the immunoprecipitation market, along with their company profiles, recent developments, and key market strategies.

Research Coverage:
The market study covers the immunoprecipitation market across various segments. It aims at estimating the market size and the growth potential of this market across different segments, on the basis of product, analyte type, product, end user, and region. The study also includes an in-depth competitive analysis of the key players in the market, along with their company profiles, key observations related to their product and business offerings, recent developments, and key market strategies.

Key Benefits of Buying the Report:
The report will help market leaders/new entrants in this market and provide information on the closest approximations of the revenue numbers for the overall immunoprecipitation market and its subsegments. This report will help the stakeholders to understand the competitive landscape, to gain more insights to better position their businesses, and to plan suitable go-to-market strategies. The report will also help the stakeholders to understand the pulse of the market and provide information on key market drivers, restraints, and opportunities.


  • INTRODUCTION
    • OBJECTIVES OF THE STUDY
    • MARKET DEFINITION
    • MARKET SCOPE
      • MARKETS COVERED
      • YEARS CONSIDERED FOR THE STUDY
    • CURRENCY
    • STAKEHOLDERS
    • LIMITATIONS
  • RESEARCH METHODOLOGY
    • RESEARCH APPROACH
      • SECONDARY RESEARCH
      • PRIMARY RESEARCH
    • MARKET SIZE ESTIMATION
    • DATA TRIANGULATION APPROACH
    • ASSUMPTIONS FOR THE STUDY
  • EXECUTIVE SUMMARY
  • PREMIUM INSIGHTS
    • IMMUNOPRECIPITATION: MARKET OVERVIEW
    • IMMUNOPRECIPITATION MARKET, BY PRODUCT (2018–2024)
    • NORTH AMERICA: IMMUNOPRECIPITATION MARKET, BY TYPE (2018)
  • MARKET OVERVIEW
    • INTRODUCTION
    • MARKET DYNAMICS
      • MARKET DRIVERS
      • RESTRAINTS
      • OPPORTUNITIES
      • CHALLENGES
  • IMMUNOPRECIPITATION MARKET, BY TYPE
    • INTRODUCTION
      • Table IMMUNOPRECIPITATION MARKET, BY TYPE, 2016–2024 (USD MILLION)
    • INDIVIDUAL IMMUNOPRECIPITATION
      • INCREASING DEMAND FOR BIOLOGICS IS DRIVING THE GROWTH OF THE MARKET
        • Table INDIVIDUAL IMMUNOPRECIPITATION MARKET, BY REGION, 2016–2024 (USD MILLION)
        • Table NORTH AMERICA: INDIVIDUAL IMMUNOPRECIPITATION MARKET, BY COUNTRY, 2016–2024 (USD MILLION)
    • CO-IMMUNOPRECIPITATION
      • INCREASING USE OF CO-IP TO STUDY PROTEIN COMPLEXES FORMS A KEY MARKET DRIVER
        • Table CO-IMMUNOPRECIPITATION MARKET, BY REGION, 2016–2024 (USD MILLION)
        • Table NORTH AMERICA: CO-IMMUNOPRECIPITATION MARKET, BY COUNTRY, 2016–2024 (USD MILLION)
    • CHROMATIN IMMUNOPRECIPITATION
      • GROWING ADOPTION OF HIGH-THROUGHPUT TECHNOLOGIES WILL CONTRIBUTE TO ADOPTION OF CHIP
        • Table CHROMATIN IMMUNOPRECIPITATION MARKET, BY REGION, 2016–2024 (USD MILLION)
        • Table NORTH AMERICA: CHROMATIN IMMUNOPRECIPITATION MARKET, BY COUNTRY, 2016–2024 (USD MILLION)
    • RNA IMMUNOPRECIPITATION
      • AVAILABILITY OF GOVERNMENT FUNDING WILL DRIVE THE ADOPTION OF RIP KITS
        • Table RNA IMMUNOPRECIPITATION MARKET, BY REGION, 2016–2024 (USD MILLION)
        • Table NORTH AMERICA: RNA IMMUNOPRECIPITATION MARKET, BY COUNTRY, 2016–2024 (USD MILLION)
  • IMMUNOPRECIPITATION MARKET, BY PRODUCT
    • INTRODUCTION
      • Table IMMUNOPRECIPITATION MARKET, BY PRODUCT, 2016–2024 (USD MILLION)
    • KITS
      • KITS SEGMENT TO ACCOUNT FOR THE LARGEST SHARE OF THE IMMUNOPRECIPITATION MARKET DURING THE FORECAST PERIOD
        • Table IMMUNOPRECIPITATION KITS MARKET, BY REGION, 2016–2024 (USD MILLION)
        • Table NORTH AMERICA: IMMUNOPRECIPITATION KITS MARKET, BY COUNTRY, 2016–2024 (USD MILLION)
    • REAGENTS
      • Table IMMUNOPRECIPITATION REAGENTS MARKET, BY REGION, 2016–2024 (USD MILLION)
      • Table NORTH AMERICA: IMMUNOPRECIPITATION REAGENTS MARKET, BY COUNTRY, 2016–2024 (USD MILLION)
      • Table IMMUNOPRECIPITATION REAGENTS MARKET, BY TYPE, 2016–2024 (USD MILLION)
      • ANTIBODIES
        • Table IMMUNOPRECIPITATION ANTIBODIES MARKET, BY REGION, 2016–2024 (USD MILLION)
        • Table NORTH AMERICA: IMMUNOPRECIPITATION ANTIBODIES MARKET, BY COUNTRY, 2016–2024 (USD MILLION)
        • Table IMMUNOPRECIPITATION ANTIBODIES MARKET, BY TYPE, 2016–2024 (USD MILLION)
        • Table IMMUNOPRECIPITATION MARKET FOR PRIMARY ANTIBODIES, BY REGION, 2016–2024 (USD MILLION)
        • Table NORTH AMERICA: IMMUNOPRECIPITATION MARKET FOR PRIMARY ANTIBODIES, BY COUNTRY, 2016–2024 (USD MILLION)
        • Table IMMUNOPRECIPITATION MARKET FOR SECONDARY ANTIBODIES, BY REGION, 2016–2024 (USD MILLION)
        • Table NORTH AMERICA: IMMUNOPRECIPITATION MARKET FOR SECONDARY ANTIBODIES, BY COUNTRY, 2016–2024 (USD MILLION)
      • BEADS
        • Table IMMUNOPRECIPITATION BEADS MARKET, BY REGION, 2016–2024 (USD MILLION)
        • Table NORTH AMERICA: IMMUNOPRECIPITATION BEADS MARKET, BY COUNTRY, 2016–2024 (USD MILLION)
        • Table IMMUNOPRECIPITATION BEADS MARKET, BY TYPE, 2016–2024 (USD MILLION)
        • Table IMMUNOPRECIPITATION MARKET FOR AGAROSE BEADS, BY REGION, 2016–2024 (USD MILLION)
        • Table NORTH AMERICA: IMMUNOPRECIPITATION MARKET FOR AGAROSE BEADS, BY COUNTRY, 2016– 2024 (USD MILLION)
        • Table IMMUNOPRECIPITATION MARKET FOR MAGNETIC BEADS, BY REGION, 2016–2024 (USD MILLION)
        • Table NORTH AMERICA: IMMUNOPRECIPITATION MARKET FOR MAGNETIC BEADS, BY COUNTRY, 2016– 2024 (USD MILLION)
        • Table IMMUNOPRECIPITATION BUFFERS MARKET, BY REGION, 2016–2024 (USD MILLION)
        • Table NORTH AMERICA: IMMUNOPRECIPITATION BUFFERS MARKET, BY COUNTRY, 2016–2024 (USD MILLION)
    • ACCESSORIES
      • Table IMMUNOPRECIPITATION ACCESSORIES MARKET, BY REGION, 2016–2024 (USD MILLION)
      • Table NORTH AMERICA: IMMUNOPRECIPITATION ACCESSORIES MARKET, BY COUNTRY, 2016–2024 (USD MILLION)
  • IMMUNOPRECIPITATION MARKET, BY END USER
    • INTRODUCTION
      • Table IMMUNOPRECIPITATION MARKET, BY END USER, 2016–2024 (USD MILLION)
    • ACADEMIC & RESEARCH INSTITUTES
      • ACADEMIC & RESEARCH INSTITUTES ARE THE LARGEST END USERS OF IMMUNOPRECIPITATION
        • Table IMMUNOPRECIPITATION MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2016–2024 (USD MILLION)
        • Table NORTH AMERICA: IMMUNOPRECIPITATION MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2016–2024 (USD MILLION)
    • PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
      • INCREASING DEMAND FOR PROTEIN-BASED DRUGS TO DRIVE THE DEMAND FOR IMMUNOPRECIPITATION IN THIS END-USER SEGMENT
        • Table IMMUNOPRECIPITATION MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2016–2024 (USD MILLION)
        • Table NORTH AMERICA: IMMUNOPRECIPITATION MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2016–2024 (USD MILLION)
    • CONTRACT RESEARCH ORGANIZATIONS
      • GROWTH IN OUTSOURCING OF PROTEIN PURIFICATION ACTIVITIES - A MAJOR FACTOR DRIVING THE DEMAND FOR IMMUNOPRECIPITATION TECHNOLOGIES IN CONTRACT RESEARCH ORGANIZATIONS
        • Table IMMUNOPRECIPITATION MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2016–2024 (USD MILLION)
        • Table NORTH AMERICA: IMMUNOPRECIPITATION MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2016–2024 (USD MILLION)
  • IMMUNOPRECIPITATION MARKET, BY REGION
    • INTRODUCTION
      • Table IMMUNOPRECIPITATION MARKET, BY REGION, 2016–2024 (USD MILLION)
    • NORTH AMERICA
      • Table NORTH AMERICA: IMMUNOPRECIPITATION MARKET, BY COUNTRY, 2016–2024 (USD MILLION)
      • Table NORTH AMERICA: IMMUNOPRECIPITATION MARKET, BY PRODUCT, 2016–2024 (USD MILLION)
      • Table NORTH AMERICA: IMMUNOPRECIPITATION REAGENTS MARKET, BY TYPE, 2016–2024 (USD MILLION)
      • Table NORTH AMERICA: IMMUNOPRECIPITATION ANTIBODIES MARKET, BY TYPE, 2016–2024 (USD MILLION)
      • Table NORTH AMERICA: IMMUNOPRECIPITATION BEADS MARKET, BY TYPE, 2016–2024 (USD MILLION)
      • Table NORTH AMERICA: IMMUNOPRECIPITATION MARKET, BY TYPE, 2016–2024 (USD MILLION)
      • Table NORTH AMERICA: IMMUNOPRECIPITATION MARKET, BY END USER, 2016–2024 (USD MILLION)
      • US
        • Table US: IMMUNOPRECIPITATION MARKET, BY PRODUCT, 2016–2024 (USD MILLION)
        • Table US: IMMUNOPRECIPITATION REAGENTS MARKET, BY TYPE, 2016–2024 (USD MILLION)
        • Table US: IMMUNOPRECIPITATION ANTIBODIES MARKET, BY TYPE, 2016–2024 (USD MILLION)
        • Table US: IMMUNOPRECIPITATION BEADS MARKET, BY TYPE, 2016–2024 (USD MILLION)
        • Table US: IMMUNOPRECIPITATION MARKET, BY TYPE, 2016–2024 (USD MILLION)
        • Table US: IMMUNOPRECIPITATION MARKET, BY END USER, 2016–2024 (USD MILLION)
      • CANADA
        • Table CANADA: IMMUNOPRECIPITATION MARKET, BY PRODUCT, 2016–2024 (USD MILLION)
        • Table CANADA: IMMUNOPRECIPITATION REAGENTS MARKET, BY TYPE, 2016–2024 (USD MILLION)
        • Table CANADA: IMMUNOPRECIPITATION ANTIBODIES MARKET, BY TYPE, 2016–2024 (USD MILLION)
        • Table CANADA: IMMUNOPRECIPITATION BEADS MARKET, BY TYPE, 2016–2024 (USD MILLION)
        • Table CANADA: IMMUNOPRECIPITATION MARKET, BY TYPE, 2016–2024 (USD MILLION)
        • Table CANADA: IMMUNOPRECIPITATION MARKET, BY END USER, 2016–2024 (USD MILLION)
    • EUROPE
      • GROWTH OF THE LIFE SCIENCES SECTOR WILL SUPPORT THE DEMAND FOR IMMUNOPRECIPITATION
        • Table EUROPE: IMMUNOPRECIPITATION MARKET, BY PRODUCT, 2016–2024 (USD MILLION)
        • Table EUROPE: IMMUNOPRECIPITATION REAGENTS MARKET, BY TYPE, 2016–2024 (USD MILLION)
        • Table EUROPE: IMMUNOPRECIPITATION ANTIBODIES MARKET, BY TYPE, 2016–2024 (USD MILLION)
        • Table EUROPE: IMMUNOPRECIPITATION BEADS MARKET, BY TYPE, 2016–2024 (USD MILLION)
        • Table EUROPE: IMMUNOPRECIPITATION MARKET, BY TYPE, 2016–2024 (USD MILLION)
        • Table EUROPE: IMMUNOPRECIPITATION MARKET, BY END USER, 2016–2024 (USD MILLION)
    • ASIA PACIFIC
      • INCREASING DEMAND FOR NOVEL ANTIBODY AND PROTEIN-BASED DRUGS SUPPORT MARKET GROWTH IN THE ASIA PACIFIC
        • Table ASIA PACIFIC: IMMUNOPRECIPITATION MARKET, BY PRODUCT, 2016–2024 (USD MILLION)
        • Table ASIA PACIFIC: IMMUNOPRECIPITATION REAGENTS MARKET, BY TYPE, 2016–2024 (USD MILLION)
        • Table ASIA PACIFIC: IMMUNOPRECIPITATION ANTIBODIES MARKET, BY TYPE, 2016–2024 (USD MILLION)
        • Table ASIA PACIFIC: IMMUNOPRECIPITATION BEADS MARKET, BY TYPE, 2016–2024 (USD MILLION)
        • Table ASIA PACIFIC: IMMUNOPRECIPITATION MARKET, BY TYPE, 2016–2024 (USD MILLION)
        • Table ASIA PACIFIC: IMMUNOPRECIPITATION MARKET, BY END USER, 2016–2024 (USD MILLION)
    • REST OF THE WORLD
      • Table ROW: IMMUNOPRECIPITATION MARKET, BY PRODUCT, 2016–2024 (USD MILLION)
      • Table ROW: IMMUNOPRECIPITATION REAGENTS MARKET, BY TYPE, 2016–2024 (USD MILLION)
      • Table ROW: IMMUNOPRECIPITATION ANTIBODIES MARKET, BY TYPE, 2016–2024 (USD MILLION)
      • Table ROW: IMMUNOPRECIPITATION BEADS MARKET, BY TYPE, 2016–2024 (USD MILLION)
      • Table ROW: IMMUNOPRECIPITATION MARKET, BY TYPE, 2016–2024 (USD MILLION)
      • Table ROW: IMMUNOPRECIPITATION MARKET, BY END USER, 2016–2024 (USD MILLION)
  • COMPETITIVE LANDSCAPE
    • OVERVIEW
    • VENDOR BENCHMARKING
    • COMPETITIVE LEADERSHIP MAPPING
      • VISIONARY LEADERS
      • INNOVATORS
      • DYNAMIC DIFFERENTIATORS
      • EMERGING COMPANIES
    • MARKET RANKING ANALYSIS, 2017
    • COMPETITIVE SITUATION AND TRENDS
      • EXPANSIONS
        • Table EXPANSIONS, 2016–2018
      • COLLABORATIONS, PARTNERSHIPS, AND AGREEMENTS
        • Table COLLABORATIONS, PARTNERSHIPS, AND AGREEMENTS, 2016–2018
      • PRODUCT LAUNCHES
        • Table PRODUCT LAUNCHES, 2016–2018
      • ACQUISITIONS
        • Table ACQUISITIONS, 2016-2018
  • COMPANY PROFILES
    • THERMO FISHER SCIENTIFIC
      • BUSINESS OVERVIEW
      • PRODUCTS OFFERED
      • RECENT DEVELOPMENTS
      • MNM VIEW
    • ABCAM
      • BUSINESS OVERVIEW
      • PRODUCTS OFFERED
      • RECENT DEVELOPMENTS
      • MNM VIEW
    • GENSCRIPT
      • BUSINESS OVERVIEW
      • PRODUCTS OFFERED
      • RECENT DEVELOPMENTS
      • MNM VIEW
    • MERCK KGAA
      • BUSINESS OVERVIEW
      • PRODUCTS OFFERED
      • RECENT DEVELOPMENTS
      • MNM VIEW
    • BIO-RAD LABORATORIES
      • BUSINESS OVERVIEW
      • PRODUCTS OFFERED
      • MNM VIEW
    • BIOLEGEND
      • BUSINESS OVERVIEW
      • PRODUCTS OFFERED
      • RECENT DEVELOPMENTS
      • MNM VIEW
    • TAKARA BIO
      • BUSINESS OVERVIEW
      • PRODUCTS OFFERED
      • MNM VIEW
    • ROCKLAND IMMUNOCHEMICALS
      • BUSINESS OVERVIEW
      • PRODUCTS OFFERED
      • MNM VIEW
    • CELL SIGNALING TECHNOLOGY
      • BUSINESS OVERVIEW
      • PRODUCTS OFFERED
      • RECENT DEVELOPMENTS
    • GENO TECHNOLOGY
      • BUSINESS OVERVIEW
      • PRODUCTS OFFERED
  • APPENDIX
    • DISCUSSION GUIDE
    • KNOWLEDGE STORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
    • AVAILABLE CUSTOMIZATIONS
    • RELATED REPORTS
    • AUTHOR DETAILS

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook